Department of Biosystems, Biosensors Group, KU Leuven, Willem de Croylaan 42, 3001 Leuven, Belgium.
FOx Biosystems, Bioville, Agoralaan Abis, 3590 Diepenbeek, Belgium.
Biosens Bioelectron. 2021 Nov 15;192:113549. doi: 10.1016/j.bios.2021.113549. Epub 2021 Aug 8.
We present an innovative multiplexing concept on a fiber optic surface plasmon resonance (FO-SPR) platform and demonstrate for the first time the simultaneous detection of two targets using the same FO sensor probe. Co(III)-NTA chemistry was used for oriented and stable co-immobilization of two different His-tagged bioreceptors. T2C2 and MDTCS (i.e. fragments of the ADAMTS13 metalloprotease linked to the thrombotic thrombocytopenic purpura disorder) served as model system bioreceptors together with their respective targets (4B9 and II-1 antibodies). Gold nanoparticles were used here in an original way for discriminating the two targets in the same sample, in addition to their traditional signal amplification-role. After verifying the specificity of the selected model system, we studied the bioreceptor surface density and immobilization order. Innovative approach to lower the bioreceptor concentration below surface saturation resulted in an optimal detection of both targets, whereas the order of immobilization of the two bioreceptors did not give any significant difference. By sequentially immobilizing the T2C2 and MDTC bioreceptors, we established calibration curves in buffer and 100-fold diluted human blood plasma. This resulted in calculated limits of detection of 3.38 and 2.31 ng/mL in diluted plasma for 4B9 and II-1, respectively, indicating almost the same sensitivity as in buffer. Importantly, we also proved the applicability of the established calibration curves for quantifying the targets at random and more realistic ratios, directed by the design of experiments. This multiplexing study further expands the repertoire of applications on the FO-SPR biosensing platform, which together with its intrinsic features opens up great opportunities for diagnostics and life sciences.
我们提出了一种光纤表面等离子体共振(FO-SPR)平台上的创新复用概念,并首次展示了使用同一 FO 传感器探针同时检测两个目标的方法。我们使用 Co(III)-NTA 化学将两种不同的 His 标记生物受体定向且稳定地共固定。T2C2 和 MDTCS(即与血栓性血小板减少性紫癜疾病相关的 ADAMTS13 金属蛋白酶的片段)与各自的靶标(4B9 和 II-1 抗体)一起作为模型系统生物受体。金纳米粒子在这里被用于以新颖的方式在同一样本中区分两种靶标,除了它们的传统信号放大作用。在验证所选模型系统的特异性之后,我们研究了生物受体的表面密度和固定顺序。通过将生物受体浓度降低到表面饱和以下的创新方法,实现了对两种靶标的最佳检测,而两种生物受体的固定顺序没有产生任何显著差异。通过顺序固定 T2C2 和 MDTC 生物受体,我们在缓冲液和 100 倍稀释的人血浆中建立了校准曲线。这导致在稀释的血浆中,4B9 和 II-1 的计算检测限分别为 3.38 和 2.31 ng/mL,表明与缓冲液中的灵敏度几乎相同。重要的是,我们还通过实验设计证明了建立的校准曲线在随机和更现实的比例下定量检测目标的适用性。这项多重分析研究进一步扩展了 FO-SPR 生物传感平台的应用范围,该平台及其固有特性为诊断和生命科学开辟了巨大的机会。